More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

SAN DIEGO - Regulus Therapeutics Inc . (NASDAQ:RGLS), a biopharmaceutical company currently trading at $1.17 per share, today announced significant clinical and regulatory advancements in its ...

It also reduced the risk of kidney failure and cut the risk of death from heart disease by about 5% in adults with both type 2 diabetes and chronic kidney disease, the company said in a news release.

Statins, which are prescription drugs that can reduce cholesterol levels and lower the risk for heart disease, don’t affect kidney function, new research shows. Investigators found that taking a ...

In its early stages, kidney disease may not cause any symptoms or signs. However, as it progresses, it can cause symptoms such as itchy skin, pruritus, and a rash. Around 35.5 million adults in ...

The SCD previously received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for adults with AKI ... these patients may face chronic kidney disease or end-stage renal ...

In most cases, CKD is caused by diabetes, hypertension, or a group of infections known as glomerulonephritis, but it may also be caused by autoimmune diseases like lupus; genetic disorders like ...